Compare SPRY & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPRY | TPB |
|---|---|---|
| Founded | 2015 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Tobacco |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 860.0M | 2.4B |
| IPO Year | 2020 | 2015 |
| Metric | SPRY | TPB |
|---|---|---|
| Price | $8.23 | $84.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $40.00 | ★ $115.00 |
| AVG Volume (30 Days) | ★ 1.0M | 439.4K |
| Earning Date | 03-09-2026 | 03-02-2026 |
| Dividend Yield | N/A | ★ 0.35% |
| EPS Growth | N/A | ★ 45.33 |
| EPS | N/A | ★ 3.11 |
| Revenue | $84,278,000.00 | ★ $463,062,000.00 |
| Revenue This Year | $90.76 | $12.04 |
| Revenue Next Year | $81.70 | $15.13 |
| P/E Ratio | ★ N/A | $27.65 |
| Revenue Growth | N/A | ★ 28.39 |
| 52 Week Low | $6.66 | $51.48 |
| 52 Week High | $18.63 | $146.90 |
| Indicator | SPRY | TPB |
|---|---|---|
| Relative Strength Index (RSI) | 36.48 | 23.22 |
| Support Level | $8.05 | $82.93 |
| Resistance Level | $10.44 | $103.76 |
| Average True Range (ATR) | 0.47 | 4.36 |
| MACD | -0.02 | -1.43 |
| Stochastic Oscillator | 15.07 | 5.51 |
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.